Fuchs, J. D., Morgan, C., Bart, P., Kochar, N., Frahm, N., Swann, E., … Tomaras, G. (2012). DNA and recombinant adenovirus serotype 35 and 5 preventive HIV-1 vaccines with Env A inserts elicit cross-clade binding and V1V2 antibodies. In Retrovirology (Vol. 9). Springer Science and Business Media LLC. https://doi.org/10.1186/1742-4690-9-s2-p136

Fuchs, J. D., C. Morgan, P. Bart, N. Kochar, N. Frahm, E. Swann, P. Gilbert, et al. “DNA and recombinant adenovirus serotype 35 and 5 preventive HIV-1 vaccines with Env A inserts elicit cross-clade binding and V1V2 antibodies.” In Retrovirology, Vol. 9. Springer Science and Business Media LLC, 2012. https://doi.org/10.1186/1742-4690-9-s2-p136.

Fuchs JD, Morgan C, Bart P, Kochar N, Frahm N, Swann E, et al. DNA and recombinant adenovirus serotype 35 and 5 preventive HIV-1 vaccines with Env A inserts elicit cross-clade binding and V1V2 antibodies. In: Retrovirology. Springer Science and Business Media LLC; 2012.

Fuchs, J. D., et al. “DNA and recombinant adenovirus serotype 35 and 5 preventive HIV-1 vaccines with Env A inserts elicit cross-clade binding and V1V2 antibodies.” Retrovirology, vol. 9, no. S2, Springer Science and Business Media LLC, 2012. Crossref, doi:10.1186/1742-4690-9-s2-p136.

Fuchs JD, Morgan C, Bart P, Kochar N, Frahm N, Swann E, Gilbert P, DeRosa S, Graham B, Nabel G, Liao H, Haynes B, Tomaras G. DNA and recombinant adenovirus serotype 35 and 5 preventive HIV-1 vaccines with Env A inserts elicit cross-clade binding and V1V2 antibodies. Retrovirology. Springer Science and Business Media LLC; 2012.